Oxford Asset Management’s Pfizer PFE Stock Holding History

Oxford Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.02M	Buy	+42,230	New	+$1.1M	0.5%	40
2025 Q4	–	Sell	-96,156	Closed	-$2.45M	–	697
2025 Q3	$2.45M	Buy	+96,156	New	+$2.37M	0.8%	12
2025 Q2	–	Sell	-52,570	Closed	-$1.33M	–	711
2025 Q1	$1.33M	Buy	52,570 +25,090	+91%	+$657K	0.61%	29
2024 Q4	$729K	Buy	+27,480	New	+$745K	0.32%	86
2018 Q4	–	Sell	-128,932	Closed	-$5.38M	–	2006
2018 Q3	$5.38M	Buy	+128,932	New	+$4.96M	0.11%	207
2018 Q1	–	Sell	-332,669	Closed	-$11.5M	–	1828
2017 Q4	$11.5M	Sell	332,669 -10,681	-3%	-$364K	0.25%	47
2017 Q3	$11.6M	Sell	343,350 -115,898	-25%	-$3.72M	0.22%	52
2017 Q2	$14.6M	Buy	+459,248	New	+$14.5M	0.29%	34

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Oxford Asset Management's PFE Position: Q2 2026 in Review

Oxford Asset Management opened a new position in Pfizer (PFE) in Q2 2026: 42,230 shares worth $1.02M. The stake represents 0.5% of the portfolio and ranks #40 among its holdings. This is a return to the name: Oxford Asset Management previously reported a position in PFE as recently as Q3 2025.

Oxford Asset Management first reported a position in PFE in Q2 2017 and has held it in 8 quarters since. The position peaked at $14.6M in Q2 2017. 2,831 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Oxford Asset Management held 42,230 shares of Pfizer worth $1.02M as of Q2 2026.
Pfizer was a new Oxford Asset Management position in Q2 2026.
Pfizer made up 0.5% of Oxford Asset Management's portfolio in Q2 2026, its #40 holding.
Oxford Asset Management first reported a position in Pfizer in Q2 2017 and has held it in 8 quarters since.
Oxford Asset Management's Pfizer position peaked at $14.6M in Q2 2017.
2,831 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.